Prevention of moderate and severe ovarian hyperstimulation syndrome a guideline

被引：20
作者：
机构：
[1] Amer Soc Reprod Med, Practice Comm, Washington, DC USA
来源：
FERTILITY AND STERILITY | 2024年 / 121卷 / 02期
关键词：
Controlled ovarian stimulation; assisted reproductive technology; gonadotropins; risk; clomiphene citrate; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; ENDOTHELIAL GROWTH-FACTOR; FINAL OOCYTE MATURATION; HIGH-RISK PATIENTS; INTRAVENOUS ALBUMIN; GNRH AGONIST; EMBRYO-TRANSFER; DOPAMINE AGONIST; TREATMENT CYCLES;
D O I：
10.1016/j.fertnstert.2023.11.013
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Ovarian hyperstimulation syndrome is a serious complication associated with assisted reproductive technology. This systematic review aims to identify who is at high risk for developing ovarian hyperstimulation syndrome, along with evidence -based strategies to prevent it and replaces the document of the same name last published in 2016. (Fertil Sterile 2024;121:230-45. (c) 2023 by American Society for Reproductive Medicine.)
引用
收藏
页码：230 / 245
页数：16
相关论文
共 117 条
[21]   Larger oocyte cohorts maximize fresh IVF cycle birth rates and availability of surplus high-quality blastocysts for cryopreservation [J].
Connell, Matthew T. ;
Richter, Kevin S. ;
Devine, Kate ;
Hill, Micah J. ;
DeCherneyl, Alan H. ;
Doyle, Joseph O. ;
Tucker, Michael J. ;
Levy, Michael J. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 38 (05) :711-723
[22]   Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome [J].
D'Angelo, Arianna ;
Amso, Nazar N. ;
Hassan, Rudaina .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (05)
[23]  
Danninger B, 1996, HUM REPROD, V11, P1597
[24]   THE OVARIAN HYPERSTIMULATION SYNDROME IN IN-VITRO FERTILIZATION - A BELGIAN MULTICENTRIC STUDY .1. CLINICAL AND BIOLOGICAL FEATURES [J].
DELVIGNE, A ;
DEMOULIN, A ;
SMITZ, J ;
DONNEZ, J ;
KONINCKX, P ;
DHONT, M ;
ENGLERT, Y ;
DELBEKE, L ;
DARCIS, L ;
GORDTS, S ;
PUTTEMANS, P ;
GERRIS, J ;
SCHOYSMAN, R ;
LEROY, F .
HUMAN REPRODUCTION, 1993, 8 (09) :1353-1360
[25]   Prevention of severe ovarian hyperstimulation by coasting [J].
Dhont, M ;
Van der Straeten, F ;
De Sutter, P .
FERTILITY AND STERILITY, 1998, 70 (05) :847-850
[26]   Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? [J].
Drakopoulos, Panagiotis ;
Blockeel, Christophe ;
Stoop, Dominic ;
Camus, Michel ;
de Vos, Michel ;
Tournaye, Herman ;
Polyzos, Nikolaos P. .
HUMAN REPRODUCTION, 2016, 31 (02) :370-376
[27]   Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study [J].
Egbase, PE ;
Al Sharhan, M ;
Grudzinskas, JG .
HUMAN REPRODUCTION, 1999, 14 (06) :1421-1425
[28]   Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial [J].
Elgindy, E. A. ;
Sibai, H. ;
Mostafa, M. I. ;
Gibreel, A. ;
Darwish, E. ;
Maghraby, H. .
HUMAN REPRODUCTION, 2018, 33 (06) :1079-1086
[29]   Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial [J].
Engmann, L. L. ;
Maslow, B. S. ;
Kaye, L. A. ;
Griffin, D. W. ;
DiLuigi, A. J. ;
Schmidt, D. W. ;
Grow, D. R. ;
Nulsen, J. C. ;
Benadiva, C. A. .
JOURNAL OF OVARIAN RESEARCH, 2019, 12
[30]   The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].
Engmann, Lawrence ;
DiLuigi, Andrea ;
Schmidt, David ;
Nulsen, John ;
Maier, Donald ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2008, 89 (01) :84-91
12345678910